4//SEC Filing
Amman Bradford K. 4
Accession 0001493152-20-024301
CIK 0001716166other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 6:21 AM ET
Size
7.5 KB
Accession
0001493152-20-024301
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-12-24$7.38/sh+1,000$7,380→ 1,000 total
Holdings
- 16,667
Stock Option
Exercise: $7.50Exp: 2024-11-18→ Common Stock (16,667 underlying) - 83,334
Stock Option
Exercise: $7.50Exp: 2023-10-22→ Common Stock (83,334 underlying)
Footnotes (2)
- [F1]83,334 stock options granted on October 22, 2018. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.
- [F2]16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001425339
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 6:21 AM ET
- Size
- 7.5 KB